REG - Gooch & Housego PLC - Issue of Equity

Gooch & HousegoAnnouncement

03/05/2023 09:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230503:nRSC2626Ya&default-theme=true

RNS Number : 2626Y  Gooch & Housego PLC  03 May 2023

 For immediate release  3 May 2023

 

 

Gooch & Housego PLC

("G&H" or the "Company")

 

Issue of Equity

 

 

Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of optical
components & systems, announces that it has applied for the admission to
trading on AIM of 11,275 new ordinary shares of 20p each in the Company
("Ordinary Shares") following the exercise of certain options over Ordinary
Shares. Dealings are expected to commence on 9 May 2023.

 

Following the issue of the 11,275 new Ordinary Shares, the total number of
Ordinary shares in issue as at the date of this notice is 25,052,194 with each
share carrying the right to one vote. There are no shares held in Treasury.
The total number of voting rights in the Company is, therefore, 25,052,194.

 

The above figure of 25,052,194 may be used by shareholders as the denominator
for the calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, the Company, under
the FCA's Disclosure and Transparency Rules.

 

 

For further information please contact:

 

 Charlie Peppiatt, Chief Executive Officer                  Gooch & Housego PLC                     +44 (0) 1460 256440

 Chris Jewell, Chief Financial Officer

 Mark Court / George Cleary                                 Buchanan                                +44 (0) 20 7466 5000

 G&H@buchanan.uk.com (mailto:G&H@buchanan.uk.com)

 Christopher Baird / David Anderson                         Investec Bank plc (Nomad & broker)      +44 (0) 20 7597 5970

 

Notes to editors

 

1.     Gooch & Housego is a photonics technology business
headquartered in Ilminster, Somerset, UK with operations in the USA and
Europe. A world leader in its field, the company researches, designs,
engineers and manufactures advanced photonic systems, components and
instrumentation for applications in the Aerospace & Defence, Industrial,
Life Sciences and Scientific Research sectors. World leading design,
development and manufacturing expertise is offered across a broad range of
complementary technologies.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEFIFEDELIVIIV